Botulinum toxin A for the management of vulvodynia

H. Yoon, W. S. Chung, B. S. Shim

Research output: Contribution to journalArticlepeer-review

78 Scopus citations


Clinically, botulinum toxin A blocks the cholinergic innervation of the target tissue. Recently, it has been proved effective not only at a neuromuscular junction but also within parasympathetic or sympathetic neural synapses. Seven women with pain on genitalia that could not be controlled with conventional pain managements were enrolled in this study. Twenty to 40 U of botulinum toxin A were used in each injection. Injection sites were the vestibule, levator ani muscle or the perineal body. Repeat injections were administered every 2 weeks if the patient's symptoms had not fully subsided. In all patients, pain had disappeared with botulinum toxin A injections. Five patients needed to be injected twice; the other two patients needed only one injection. We did not observe complications related to botulinum toxin A injections, such as pain, hemorrhage, infection, muscle paralysis or other complications. The subjective pain score improved from 8.3 to 1.4, and no one has experienced a recurrence (the follow-up period was four to 24 months, with a mean follow-up of 11.6 months). Botulinum toxin A is effective in blocking nociception. Even though further investigation and well-controlled study will be necessary, we suggest that the botulinum toxin therapy would be useful and safe in managing vulvodynia of muscular or neuroinflammatory origins.

Original languageEnglish
Pages (from-to)84-87
Number of pages4
JournalInternational Journal of Impotence Research
Issue number1
StatePublished - 2007


  • Botulinum toxin A
  • Sexual pain
  • Vulvodynia


Dive into the research topics of 'Botulinum toxin A for the management of vulvodynia'. Together they form a unique fingerprint.

Cite this